What Researchers Did
The author wrote a review for hospital doctors that describes how hyperbaric oxygen is delivered and which conditions it is used to treat.
What They Found
This narrative review describes hyperbaric oxygen (HBO2) as breathing 100% oxygen at pressures above 1.4 times atmospheric pressure, given in single-person (monoplace) or multi-person (multiplace) chambers. Most clinical exposures are between 2 and 2.4 atm abs for about 2 hours. The review says HBO2 raises blood and tissue oxygen levels and is used for decompression sickness, arterial gas embolism, carbon monoxide poisoning, crush injury, ischemic flaps and grafts, and some acute arterial occlusions. It also lists sudden sensorineural hearing loss, life- or limb-threatening infections, and ischemic wounds such as diabetic lower extremity wounds, late effects of radiation, and refractory osteomyelitis. The abstract states that clinical trials support efficacy for acute carbon monoxide poisoning, diabetic lower extremity wounds, crush injury, and radiation necrosis.
What This Means for Canadian Patients
For people with carbon monoxide poisoning, the abstract says HBO2 speeds the wash-out of carbon monoxide and that clinical trials support its efficacy for acute poisoning. The abstract does not report patient outcomes, numbers, or a comparison with other treatments. Anyone considering HBO2 should talk with their physician about whether it fits their situation.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The abstract describes a narrative review with no stated search method, pooled data, or patient numbers, so it does not show how strong the evidence is for each condition listed.